Submit Content
Get the latest delivered to your inbox
Privacy Policy

Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2012, the Group achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 129,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.

 

Novartis is on Twitter. Sign up to follow @Novartis at twitter.com/novartis.

    Novartis Accelerates Production of Life-Saving Malaria Treatment Coartem® Image

    POSTED 

    01-18-06

    Novartis Accelerates Production of Life-Saving Malaria Treatment Coartem®

    Basel, Switzerland--Novartis announced today that it is on track to produce 100 million treatment courses of its anti-malarial Coartem (artemether/lumefantrine) in 2006 (up from 30 million in 2005), if orders are placed by malaria-endemic developing countries in a tim...

    Novartis Employees Honored with Energy Excellence Awards Image

    POSTED 

    12-08-05

    Novartis Employees Honored with Energy Excellence Awards

    Basel, Switzerland - Five Novartis project team leaders from sites in Bangladesh, India, Ireland and the US were honored today with the Energy Excellence Awards for their exceptional contributions to improving energy efficiency and reducing carbon dioxide (CO2) emissi...

    Tears Will Get You Sympathy; Sweat Will Get You Change Image

    POSTED 

    11-25-05

    Tears Will Get You Sympathy; Sweat Will Get You Change

    Basel - Private initiative can change the world. That was the joint message issued by well-known speakers from a wide range of backgrounds at the international 2005 Symposium of the Novartis Foundation for Sustainable Development in Basel/ Switzerland. The large audie...

    WHO and Novartis Deliver Free Leprosy Treatment for all Patients Worldwide Image

    POSTED 

    11-07-05

    WHO and Novartis Deliver Free Leprosy Treatment for all Patients Worldwide

    All leprosy patients in the world will continue to benefit from free medicines under an agreement signed today by the World Health Organization (WHO) and the pharmaceutical company, Novartis AG. This extends the current agreement until the end of 2010 and is valued at...

    World Experts Convene in Tanzania to Address Tuberculosis (TB) Emergency Image

    POSTED 

    10-17-05

    World Experts Convene in Tanzania to Address Tuberculosis (TB) Emergency

    Bagamoyo, Tanzania - International experts at a symposium sponsored by the Novartis Institute for Tropical Diseases (NITD) are meeting to review advances in research on tuberculosis (TB) therapies. The meeting is addressing goals and problems of TB control with focus ...

    Novartis Logo

    Novartis

    Novartis

    Join today and get the latest delivered to your inbox